Stock 002864 SHAANXI PANLONG PHARMACEUTICAL GROUP LIMITED BY SHARE LTD
Add to a list
To use this feature you must be a member
Log inSign up

News Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd

Equities

002864

CNE1000032C9

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 23/06/2024 BST 		5-day change 1st Jan Change
25.81 CNY -3.04% Intraday chart for Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd -6.42% -32.94%
04-25 Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
04-25 Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Shaanxi Panlong Pharmaceutical Group Limited by Share Ltd Announces Final Dividend on A Shares for the Year 2023, Payable on 03 June 2024
CI
Shaanxi Panlong Pharmaceutical Group Limited by Share Ltd Approves Cash Dividend for the Year 2023
CI
Shaanxi Panlong Pharmaceutical Group Limited by Share Ltd Proposes Final Cash Dividend for the Year 2023
CI
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Tranche Update on Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's Equity Buyback Plan announced on March 14, 2024.
CI
Panlong Pharmaceutical Plans 20 Million Yuan Share Buyback
MT
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd announces an Equity Buyback for CNY 20 million worth of its shares.
CI
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd authorizes a Buyback Plan.
CI
Panlong Pharmaceutical Gets Sanitary License
MT
Panlong Pharmaceutical Gets Certificate for Shaanxi Good Trademark
MT
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd announced that it has received CNY 301.999975 million in funding
CI
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Panlong Pharma Completes Registration of New Medical Clinic
MT
Shaanxi Panlong Pharmaceutical Group Limited by Share Ltd. Approves Cash Dividend for 2022, Payable on May 31, 2023
CI
Chinese Shares Retreat; Panlong Pharma Falls 7% on 302 Million Yuan Share Sale
MT
Shaanxi Panlong Pharma Selling 302 Million Yuan Shares to Fund New Projects
MT
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Shaanxi Panlong Pharmaceutical Group Limited by Share Ltd. Proposes Final Cash Dividend for 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 002864 Stock
  4. News Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd